MultiCell Technologies, Inc. Stock OTC Bulletin Board
Equities
US62544S2005
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2015 | MultiCell Technologies, Inc. Auditor Raises 'Going Concern' Doubt | CI |
2014 | MultiCell Technologies Files Novel Antibody-Drug Conjugate Patent Application | CI |
Financials (USD)
Sales 2013 | 49.32K | Sales 2014 | 49.32K | Capitalization | 2.16M |
---|---|---|---|---|---|
Net income 2013 | -1M | Net income 2014 | - | EV / Sales 2013 | 34.9 x |
Net cash position 2013 | 39.11K | Net Debt 2014 | 90.04K | EV / Sales 2014 | 45.7 x |
P/E ratio 2013 |
-1.09
x | P/E ratio 2014 |
-4.9
x | Employees | - |
Yield 2013 * |
-
| Yield 2014 |
-
| Free-Float | 90.01% |
1st Jan change | Capi. | |
---|---|---|
+29.77% | 49.46B | |
+1.00% | 42.58B | |
+49.62% | 42.49B | |
-5.26% | 29.09B | |
+13.68% | 26.61B | |
-22.99% | 18.64B | |
+8.22% | 13.16B | |
+32.41% | 12.55B | |
+24.01% | 12.1B |